Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-27T00:55:56.681Z Has data issue: false hasContentIssue false

Lithium for prevention of Alzheimer's disease

Published online by Cambridge University Press:  02 January 2018

T. Terao*
Affiliation:
Oita University Faculty of Medicine, Oita, Japan. Email: terao@med.oita-u.ac.jp
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © Royal College of Psychiatrists, 2007 

Nunes et al (Reference Nunes, Forlenza and Gattaz2007) reported that the prevalence of Alzheimer's disease in a group of elderly patients with bipolar disorder who were on continuous lithium treatment was significantly less than in a similar group without recent lithium therapy. After controlling for age, lithium use remained associated with a smaller risk of Alzheimer's disease (age-adjusted OR=0.079, 95% CI 0.020–0.321). Conversely, Dunn et al (Reference Dunn, Holmes and Mullee2005) showed that patients who received lithium had a significantly higher risk of dementia than those who did not (age-adjusted OR=1.8, 95% CI 1.1–2.8).

Nunes et al (Reference Nunes, Forlenza and Gattaz2007) found no differences between the lithium and the comparison group in neuropsychological performance after excluding patients with Alzheimer's disease. This is in accordance with our study using Mini-Mental State Examination (MMSE) scores (Reference Terao, Nakano and InoueTerao et al, 2006). Our study, however, showed that patients with present and/or past history of lithium treatment had significantly better MMSE scores than patients without any history of lithium treatment (Reference Terao, Nakano and InoueTerao et al, 2006). It is important to further investigate lithium in the prevention of Alzheimer's dementia with a large number of patients in prospective studies.

If lithium has a preventive effect for Alzheimer's disease, there may be two possible mechanisms. First, it might indirectly prevent dementia via its prophylactic effects on mood disorders, because the rate of dementia increased 13% with every episode leading to admission for patients with depressive disorder and 6% for patients with bipolar disorder, when adjusted for differences in age and gender (Reference Kessing and AndersenKessing & Andersen, 2004). Second, lithium might directly prevent dementia via its inhibition of glycogen synthase kinase 3 (GSK-3) alpha (Reference Phiel, Wilson and LeePhiel et al, 2003) and GSK-3 beta (Reference Phiel and KleinPhiel & Klein, 2001). Although Nunes et al (Reference Nunes, Forlenza and Gattaz2007) found no significant differences in the number of previous depressive and manic episodes between the lithium and comparison groups, at present both possibilities should be borne in mind.

References

Dunn, N. Holmes, C. & Mullee, M. (2005) Does lithium therapy protect against the onset of dementia? Alzheimer Disease and Associated Disorders, 19 2022.Google Scholar
Kessing, L. V. & Andersen, P. K. (2004) Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? Journal of Neurology Neurosurgery and Psychiatry, 75 16621666.CrossRefGoogle ScholarPubMed
Nunes, P. V. Forlenza, O. V. & Gattaz, W. F. (2007) Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. British Journal of Psychiatry, 190 359360.Google Scholar
Phiel, C. J. & Klein, P. S. (2001) Molecular targets of lithium action. Annual Review of Pharmacology and Toxicology, 41 789813.Google Scholar
Phiel, C. J. Wilson, C. A. Lee, V. M.-Y. et al (2003) GSK-3 alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature, 423 435439.Google Scholar
Terao, T. Nakano, H. Inoue, Y. et al (2006) Lithium and dementia: a preliminary study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30 11251128.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.